This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gilberto F. Chávez, MD, MPH; Joseph Mulinare, MD, MSPH; Larry D. Edmonds, MSPH

JAMA. 1991;265(24):3270-3274.

Abstract
Nationwide surveillance of Rh hemolytic disease of the newborn (RhHDN) indicates that, after a substantial decline in incidence, reported rates reached a plateau in the late 1970s. We conducted a study designed to validate RhHDN surveillance data, to obtain corrected incidence estimates, and to identify potential reasons for the reported plateau. We obtained data from the Birth Defects Monitoring Program, a national surveillance system that collects data from public and private hospitals participating voluntarily. We asked hospitals for copies of the medical records for all infants discharged with a code for RhHDN and for a sample of the medical records of infants discharged with a code for other and unspecified hemolytic disease during 1986. The estimated incidence rate of RhHDN was 10.6 per 10 000 total births, with some regional variations. Our findings indicate that, despite the availability of an effective preventive measure, RhHDN continues to contribute significantly to infant morbidity and mortality in the United States.

(JAMA. 1991;265:3270-3274)

Author Affiliations
From the Birth Defects and Genetic Diseases Branch, Division of Birth Defects and Developmental Disabilities, Center for Environmental Health and Injury Control, Centers for Disease Control, Atlanta, Ga. Dr Chavez is presently with the Division of Reproductive Health, Centers for Disease Control, on assignment to the Maternal and Child Health Branch of the California Department of Health Services, Sacramento.

Footnotes
Reprint requests to Birth Defects and Genetic Diseases Branch, Centers for Disease Control, 1600 Clifton Rd, MS-F37, Atlanta, GA 30333 (Mr Edmonds).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Haemolytic disease of the newborn due to anti-c
Abourazzak et al.
BMJ Case Reports 2009;2009:bcr0920080987-bcr0920080987.
ABSTRACT | FULL TEXT  

Determination of RhD Zygosity: Comparison of a Double Amplification Refractory Mutation System Approach and a Multiplex Real-Time Quantitative PCR Approach
Chiu et al.
Clin. Chem. 2001;47:667-672.
ABSTRACT | FULL TEXT  

Neurodevelopmental Abnormalities and Schizophrenia: A Family Affair
Wyatt
Arch Gen Psychiatry 1996;53:11-15.
ABSTRACT  

The New and the Old -- Molecular Diagnostics and Hemolytic Disease of the Newborn
Luban
NEJM 1993;329:658-660.
FULL TEXT  

Hemolytic Disease of the Newborn: Lowest Achievable Incidence Rates
Hensleigh
JAMA 1991;266:2562-2562.
ABSTRACT